Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.
Leuk Res
; 35(12): 1557-63, 2011 Dec.
Article
en En
| MEDLINE
| ID: mdl-21764130
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Quinazolinas
/
Enfermedades Cardiovasculares
/
Privación de Tratamiento
/
Trombocitemia Esencial
Tipo de estudio:
Etiology_studies
/
Evaluation_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2011
Tipo del documento:
Article